T 0501/09 (Apoptosis/AMGEN INC.) of 25.6.2013

European Case Law Identifier: ECLI:EP:BA:2013:T050109.20130625
Date of decision: 25 June 2013
Case number: T 0501/09
Application number: 96943576.7
IPC class: C07K 16/32
C07K 16/46
C12N 5/20
C12N 5/10
A61K 39/395
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 221 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Apoptosis induced by monoclonal antibody anti-Her2
Applicant name: Amgen Inc.,
Opponent name: Fresenius Biotech GmbH
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 108
European Patent Convention R 99(2)
European Patent Convention R 101(1)
Rules of procedure of the Boards of Appeal Art 12(4)
Keywords: Admissibility of appeal/patentee - statement of grounds (not filed)
Admissibility of appeal/opponent - appeal sufficiently substantiated (no)
Catchwords:

Admissibility of appeal, see points 2 to 8

Cited decisions:
G 0009/91
G 0010/91
R 0002/08
T 0220/83
T 0923/92
T 1002/92
T 0015/01
T 1557/05
T 0724/08
Citing decisions:
T 1703/10
T 0008/15
T 0198/15

16 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law